Log in
Enquire now
‌

US Patent 9707267 Beta-turn peptidomimetic cyclic compounds for treating dry eye

Patent 9707267 was granted and assigned to Mimetogen Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
‌
Mimetogen Pharmaceuticals
0
Current Assignee
‌
Mimetogen Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
97072670
Patent Inventor Names
Teresa Lama0
Garth Cumberlidge0
Horacio Uri Saragovi0
Karen Meerovitch0
Date of Patent
July 18, 2017
0
Patent Application Number
148588740
Date Filed
September 18, 2015
0
Patent Primary Examiner
‌
Marcela M Cordero Garcia
0
Patent abstract

The present invention relates to methods of treating dry eye using β-turn peptidomimetic cyclic compounds or derivatives thereof. The β-turn peptidomimetic cyclic compounds can be used alone, in combination and/or in conjunction with one or more other compounds, molecules or drugs that treat dry eye.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9707267 Beta-turn peptidomimetic cyclic compounds for treating dry eye

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.